[ad_1]
Read More »Global Blood Therapeutics (GBT) Rating Lowered to Hold at Zacks Investment Research
[ad_1]
Read More »Glanbia (GLAPY) Upgraded by Zacks Investment Research to "Hold" – BharataPress
[ad_1] Zacks Investment Research raised Glanbia's shares (OTCMKTS: GLAPY) of a sales rating to a hold in a report released on Wednesday. According to Zacks, "Glanbia Plc is engaged in the manufacturing …
Read More »Zacks: Analysts expect Adient PLC (ADNT) to post a profit of $ 1.60 per share
[ad_1]
Read More »Zacks: Analysts predict Masimo Co. (MASI) will post $ 0.72 in earnings per share
[ad_1]
Read More »